All AbMole products are for research use only, cannot be used for human consumption.
Rotigotine is a potent dopamine receptor agonist with Ki values of 0.71 nM, 4-15 nM, and 83 nM for the dopamine D3 receptor and D2, D5, D4 receptors and dopamine D1 receptor. Rotigotine a partial agonist of the 5-HT1A receptor, and an antagonist of the α2B-adrenergic receptor.
 |
Source | Bioanalysis (2014). Figure 3. Rotigotine |
| Method | competition binding assays | |
| Cell Lines | LMtk cells | |
| Concentrations | 10 μM | |
| Incubation Time | ||
| Results | There was a good correlation between functional potency of the agonists examined (Table 4) and their binding affinity versus [3H]rotigotine (Table 5) at the three dopamine receptors |
 |
Source | Bioanalysis (2014). Figure 2. Rotigotine |
| Method | competition binding assays | |
| Cell Lines | CHO cells | |
| Concentrations | 10 μM | |
| Incubation Time | ||
| Results | Equilibrium saturation assays were performed in triplicate with [3H]rotigotine and with the radiolabelled antagonist [3H]SCH23390 for D1 and D5, [3H]raclopride for D2 and [3H]spiperone for D3 and D4 receptors |
| Cell Experiment | |
|---|---|
| Cell lines | primary mesencephalic cell |
| Preparation method | To investigate the effect of rotigotine (UCB, Belgium) on the survival of THir neurons, primary mesencephalic cell cultures were treated with different concentrations of rotigotine (0.01, 0.1, 1 and 10 µM) from the 6th DIV for 8 consecutive days. Rotigotine was added with each change of the culture medium every second day from a fresh stock solution (10 mM) prepared in DMSO (0.1% final concentration). To investigate the effect of rotigotine against MPP+ or rotenone-induced cell death, rotigotine was added from the 6th DIV until the 14th DIV as described above and MPP+ (10 µM) or rotenone (20 nM) were co-administered on the 12th DIV for 48 h. |
| Concentrations | 0.01, 0.1, 1 and 10 μM |
| Incubation time | 48 h |
| Animal Experiment | |
|---|---|
| Animal models | Sprague-Dawley rats |
| Formulation | 1:10 ratio of dimethyl sulfoxide (DMSO) and 5% dextrose |
| Dosages | 0.5 or 3 mg/kg |
| Administration | s.c. |
| Molecular Weight | 315.47 |
| Formula | C19H25NOS |
| CAS Number | 99755-59-6 |
| Solubility (25°C) | DMSO ≥ 40 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related Dopamine Receptor Products |
|---|
| Nepicastat hydrochloride
Nepicastat hydrochloride is a potent and selective inhibitor of both bovine and human dopamine-β-hydroxylase with IC50 of 8.5 nM and 9 nM, respectively. |
| Naxagolide
Naxagolide (Dopazinol) is a very potent and selective D2 agonist. |
| Alizapride hydrochloride
Alizapride hydrochloride is a dopamine receptor antagonist used for the theropy of nausea and vomiting. |
| Azaperone
Azaperone is a pyridinylpiperazine and butyrophenone neuroleptic compound with sedative and antiemetic effects, which is used mainly as a tranquilizer in veterinary medicine. |
| Benztropine mesylate
Benztropine is a dopamine transporter (DAT) inhibitor with IC50 of 118 nM. Benztropine mesylate is a human D2 dopamine receptor allosteric antagonist. Benztropine mesylate also has anti-CSCs (cancer stem cells) effects. Benztropine mesylate is also an anti-histamine agent and a dopamine re-uptake inhibitor. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
